Results 121 to 130 of about 12,013,819 (212)

Platycodin D Attenuates Lipopolysaccharide‐Induced Acute Lung Injury by Modulating CD14‐Associated Inflammatory Signaling and Macrophage Phenotypic Responses

open access: yesPhytotherapy Research, EarlyView.
A mouse model of LPS‐induced acute lung injury and macrophage‐based cellular models were used to investigate the protective effects and molecular mechanisms of PLD. PLD attenuated inflammatory injury by modulating CD14‐associated TLR4/MyD88/NF‐κB signaling, downstream NLRP3 inflammasome‐associated responses, and macrophage phenotypic regulation.
Lianting Liao   +9 more
wiley   +1 more source

Saponins and Sapogenins in Inflammation Therapeutics: Glycosylation‐Dependent Mechanisms, Pharmacokinetics and Advanced Delivery Solutions

open access: yesPhytotherapy Research, EarlyView.
ABSTRACT Saponins and their aglycones, the sapogenins, are the bioactive constituents of medicinal herbs such as Panax ginseng and Astragalus membranaceus, and they act on inflammation at several levels at once. The canonical nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB), mitogen‐activated protein kinase (MAPK), and NLR family ...
Meilin Qin   +7 more
wiley   +1 more source

Microbial sensing through the non-canonical inflammasome modulates airway type 2 immunity. [PDF]

open access: yesFront Immunol
Bernard O   +8 more
europepmc   +1 more source

Photo‐responsive carbon dots for pyroptosis‐mediated anti‐tumor application

open access: yesResponsive Materials, EarlyView.
Photo‐responsive CDs generate ROS to induce tumor cell pyroptosis, thereby stimulating antitumor immunity. Abstract Pyroptosis refers to a kind of lytic programmed cell death, characterized by the release of pro‐inflammatory cytokines during the process. Owing to its immune response stimulation ability, pyroptosis has garnered considerable attention in
Lingyun Li   +5 more
wiley   +1 more source

HER2‐Targeted AIE Nanotheranostics Overcome SHR‐A1811 Resistance via Immunogenic Pyroptosis and Tumor‐Associated Macrophage Reprogramming in Breast Cancer

open access: yesSmall, EarlyView.
HER2‐targeted AIE780‐A1811 nanoparticles self‐assemble via amide coupling of a mitochondria‐directed photosensitizer with the ADC SHR‐A1811. Upon 660 nm irradiation, they generate ROS, photothermal effects, and controlled drug release, inducing immunogenic pyroptosis and M2‐to‐M1 macrophage reprogramming. This dual action remodels the immunosuppressive
Xiaohong Liu   +12 more
wiley   +1 more source

Photoactivated iridium(III) complexes drive pyroptosis–necroptosis synergy for multi‐network photoimmunotherapy of renal cell carcinoma

open access: yesSmart Molecules, EarlyView.
Photoactivated iridium(III) complexes trigger mitochondrial DNA leakage and Ca²⁺ efflux, simultaneously driving pyroptosis and necroptosis to synergistically enhance immunogenic cell death. This multi‐network cascade promotes dendritic cell maturation and CD8⁺ T cell activation, achieving potent photoimmunotherapy of renal cell carcinoma.
Xin Qin   +16 more
wiley   +1 more source

Cardiolipin inhibits the non-canonical inflammasome by preventing LPS binding to caspase-4/11. [PDF]

open access: yesEMBO J
Pizzuto M   +15 more
europepmc   +1 more source

Canonical and Non-canonical Inflammasome Activation by Outer Membrane Vesicles Derived From Bordetella pertussis. [PDF]

open access: yesFront Immunol, 2020
Elizagaray ML   +6 more
europepmc   +1 more source

A photoimmune synergizing RNA interference technology for highly effective antitumor treatment

open access: yesSmart Molecules, EarlyView.
We developed a red‐light‐activated small‐molecule photosensitizer FNBS, which enables simultaneous photodynamic immunotherapy and RNA interference. FNBS can induce pyroptosis, immunogenic cell death and RNA degradation, avoiding the carrier‐dependent delivery drawbacks of conventional RNAi therapy, converting cold tumors into hot tumors and ...
Xiang Xia   +6 more
wiley   +1 more source

Natterin bridges IFN-φ1 and non-canonical inflammasome pathways via <i>CRFB1</i>/Gbp4 to license Caspy2-mediated antibacterial immunity. [PDF]

open access: yesFront Cell Infect Microbiol
Gusso D   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy